Steroid hormone profiling reveals altered adrenal androgen production in endometriosis
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index; 17 of the 20 sources its claims cite were checked for support.
Abstract
Objective: Endometriosis is a chronic, hormone-dependent condition affecting an estimated 190 million women worldwide. Our understanding of hormonal contributions to endometriosis pathophysiology is incomplete, hindering the identification of diagnostic biomarkers and novel therapeutic targets. Although the role of estrogens is well established, research on androgens in endometriosis is limited and the contribution of adrenal-derived 11-oxygenated androgens remains largely unknown. Methods: We performed steroid androgen profiling to measure androgen concentrations in serum from healthy controls and women with laparoscopically confirmed endometriosis. We found that women with endometriosis had a distinct hormone signature characterized by systemic differences in adrenal androgen concentrations and 11-ketotestosterone excess. Using metabolomic data, we generated statistical models that showed robust discrimination between healthy controls and women with endometriosis (AUC = 0.99; positive predictive power = 96.84%, negative predictive power = 92.86%) consistent with an endometriosis-specific signature. Data were partitioned into train and validation groups to assess diagnostic potential and a refined model identified >95% of endometriosis patients in a blinded sample set. Conclusions: Collectively, these data reframe endometriosis as an androgen-dependent disorder and highlight 11-oxygenated androgens as potential diagnostic biomarkers and future therapeutic targets.
Overview
CoChat Summary
TL;DR
Serum androgen profiling in women with laparoscopically confirmed endometriosis versus healthy controls identified a distinct hormone signature marked by altered adrenal androgen production and 11-ketotestosterone excess. Statistical models using androgen concentrations discriminated endometriosis with high accuracy, including >95% sensitivity in a blinded validation set.
Key findings
In serum from healthy controls (n = 57) and women with endometriosis (n = 159), DHEA, A4, and T were significantly elevated in endometriosis (P < .0001), while DHT did not differ; 11OHA4 and 11KA4 were decreased (P < .05 and P < .0001), and 11OHT and 11KT were increased (P < .0001).
- Altered adrenal androgen metabolism was biased toward 11KT: ratios 11OHA4/A4, 11OHT/T, and 11KA4/11OHA4 were decreased, while 11KT/11OHT, 11OHT/11OHA4, and 11KT/11KA4 were increased (P < .0001).
- The 11KT/11KA4 ratio gave the most robust single discrimination between controls and endometriosis (AUC 0.968, P < .001; sensitivity 92.36%, specificity 90.91%, likelihood ratio 10.16).
- A multiple logistic regression model using androgen concentrations, age, and BMI achieved AUC 0.99 (P < .0001), positive predictive power 96.84%, and negative predictive power 92.86%; a refined model using BMI, 11OHA4, 11KA4, and 11KT identified >95% of endometriosis patients in a blinded validation set (sensitivity 95.65%; PPV 95.24%; NPV 94.74%).
Methods
Case-control serum steroid profiling: healthy controls (n = 57) and women with laparoscopically confirmed endometriosis (n = 159) were compared using LC-MS/MS to measure DHEA, A4, T, DHT, 11OHA4, 11OHT, 11KA4, and 11KT.
- Analyses included Mann–Whitney U and Kruskal–Wallis tests, Pearson correlation matrices, product/substrate ratios as proxies for enzyme activity, ROC curve analysis, and multiple logistic regression.
- For predictive modeling, data were partitioned into a training set (21 healthy controls and 21 endometriosis cases) and a blinded validation set (n = 138).
Limitations
The paper states that enzymatic activities were inferred from product/substrate ratios rather than measured directly, and that products can be metabolized further; the cells contributing to altered androgen metabolism are unknown.
- The authors state that the study primarily included participants of European ethnicity and that larger, more representative cohorts are needed to assess generalizability across demographics and endometriosis subtypes.
- The authors note a discrepancy with Mendelian randomization findings showing an inverse relationship between genetically predicted androgens and endometriosis risk; they attribute this to differences between point-of-sampling mass spectrometry and lifelong genetically predicted exposure, and call for integrated observational and genetic work to delineate causality.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
15 Valid · 1 Not valid · 2 Not checked · 98 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“the androgen receptor has been identified as an endometriosis-associated transcription factor.16”
§ Steroid hormone profiling reveals altered adrenal androgen production in endometriosis > Discussion
What the sources say
- Supportedcites [16] Yang, 2015, Integrative analysis reveals regulatory programs in endometriosis, Reprod Sci source
The “Regulatory Programs in Endometriosis” section explicitly lists androgen receptor (AR) among the endometriosis-associated transcription factors and reports differentially expressed AR target genes. No page number is provided in the supplied passage. (LLM, conf=0.95)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Changes in androgen metabolism may also have systemic effects that increase the risk of lesion formation over the life course, including changes in innate and adaptive immune cell function and inflammation,8”
§ Steroid hormone profiling reveals altered adrenal androgen production in endometriosis > Discussion
What the sources say
- Partly supportedcites [8] Ainslie, 2024, RISING STARS: androgens and immune cell function, J Endocrinol. sourceExperimental — accuracy not yet measured
The Introduction says innate and adaptive immune cells may respond to changes in androgen bioavailability, and the Final summary says such changes can alter immune function and inflammatory responses (page numbers unavailable). The paper does not establish that these effects increase the risk of lesion formation over the life course. (LLM, conf=0.86)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Androgens can regulate processes associated with the formation of endometriosis lesions”
§ Steroid hormone profiling reveals altered adrenal androgen production in endometriosis > Discussion
What the sources say
- Supportedcites [16] Yang, 2015, Integrative analysis reveals regulatory programs in endometriosis, Reprod Sci source
The Discussion (page not provided) identifies an androgen receptor regulatory program in endometriosis and suggests that its involvement may relate to regulation of human endometrial apoptosis. That supports the cautious claim that androgens can regulate a process associated with endometriosis, without establishing that they directly cause lesions to form. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Notably, the concentrations of 11KT are not diminished by oral contraceptives or gonadotropin-releasing hormone analog-mediated ovarian suppression.14”
§ Steroid hormone profiling reveals altered adrenal androgen production in endometriosis > Discussion
What the sources say
- Partly supportedcites [14] Schiffer, 2023, Classic and 11-oxygenated androgens in serum and saliva across adulthood: a cross-sectional study analyzing the impact of age, body mass index, and diurnal and menstrual cycle variation, Eur J Endocrinol sourceExperimental — accuracy not yet measured
The hormonal-contraceptives results (pp. 8–9) found no difference in serum 11KT between users and nonusers, but significantly lower salivary 11KT in users. The paper does not establish the claim specifically for oral contraceptives or address gonadotropin-releasing hormone analog-mediated ovarian suppression. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“11KT can activate androgen-dependent processes with a similar potency to T12”
§ Steroid hormone profiling reveals altered adrenal androgen production in endometriosis > Discussion
What the sources say
- Supportedcites [12] Pretorius, 2016, 11-Ketotestosterone and 11-ketodihydrotestosterone in castration resistant prostate cancer: potent androgens which can No Longer be ignored, PLoS One source
The Results section, “11KT and 11KDHT are full AR agonists,” reports that 11KT’s potency and efficacy were not statistically different from testosterone’s in an androgen-receptor transactivation assay. The Discussion also reports that 11KT induced androgen-dependent gene expression and cell growth in prostate cancer cell lines. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
72 more claims · 3 with their cited sources checked
Create a free account to see all 116 claims and every source verdict.
- Probably not a substantial claim. 20
- It may state two separate claims as one. 22
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Steroid hormone profiling reveals altered adrenal androgen production in endometriosis > Results > Endometriosis is characterized by altered concentrations of androgenic hormones
“Concentrations of 11OHA4 did not significantly differ between groups (M)”
§ Steroid hormone profiling reveals altered adrenal androgen production in endometriosis > Results > Endometriosis is characterized by altered concentrations of androgenic hormones
“5.38* (3.08-7.10)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“16/14/447.0%/41.2%/11.2%”
§ Steroid hormone profiling reveals altered adrenal androgen production in endometriosis > Results > Endometriosis is characterized by altered concentrations of androgenic hormones
Reported 11.2 · recomputed 11.764706
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Steroid hormone profiling reveals altered adrenal androgen production in endometriosis > Results > Women with endometriosis have a disease-specific hormone signature characterized by altered androgen concentrations
“The androgen analytes T, 11KA4, and 11KT exhibited best sensitivity and specificity with area under the ROC curve (AUC) values of 0.815 (P < .001), 0.822 (P < .001), and 0.815 (P < .001), respectively”
§ Steroid hormone profiling reveals altered adrenal androgen production in endometriosis > Results > Women with endometriosis have a disease-specific hormone signature characterized by altered androgen concentrations
“11KA4 (AUC 0.8145; P<0.001) and 11KT (AUC 0.8219; P<0.001)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Steroid hormone profiling reveals altered adrenal androgen production in endometriosis > Results > Development of a predictive model using supervised machine learning confirms specificity of androgen signature to endometriosis diagnosis
“AUC of 0.99 (Figure 3I; P < .0001, CI 0.9878-1.000)”
§ Steroid hormone profiling reveals altered adrenal androgen production in endometriosis > Results > Women with endometriosis have a disease-specific hormone signature characterized by altered androgen concentrations
“AUC of 0.99 (P<0.0001, CI 0.9794-1.000)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Steroid hormone profiling reveals altered adrenal androgen production in endometriosis > Materials and methods > Patient cohorts
“proliferative (days 1-14)”
§ Steroid hormone profiling reveals altered adrenal androgen production in endometriosis > Materials and methods > Patient cohorts
“secretory phase (days 14 or greater)”
1 more finding
Create a free account to see every finding of this check.
Citations
Cites
Revised American Society for Reproductive Medicine classification of endometriosis: 1996
American Society for Reproductive Medicine (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)81391-x · Cited by 3,018
Pathophysiology, diagnosis, and management of endometriosis
Horne, A. W., & Missmer, S. A. (2022) · BMJ · doi:10.1136/bmj-2022-070750 · Cited by 661
Self-citationImaging modalities for the non-invasive diagnosis of endometriosis
Nisenblat, V., Bossuyt, P. M., Farquhar, C., Johnson, N., & Hull, M. L. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009591.pub2 · Cited by 538
Berkley, K. J., Rapkin, A. J., & Papka, R. E. (2005) · Science · doi:10.1126/science.1111445 · Cited by 455
11-Oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome
O’Reilly, M. W., Kempegowda, P., Jenkinson, C., Taylor, A. E., Quanson, J. L., Storbeck, K.-H., & Arlt, W. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3285 · Cited by 267
Self-citation11-Oxygenated androgens in health and disease
Turcu, A. F., Rege, J., Auchus, R. J., & Rainey, W. E. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0336-x · Cited by 217
Danazol for pelvic pain associated with endometriosis
Farquhar, C., Prentice, A., Singla, A. A., & Selak, V. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000068.pub2 · Cited by 210 · cited 1×
“Previously, the synthetic androgen danazol was found to reduce endometriosis-associated pain, 20 but its use was stopped due to unacceptable masculinizing side effects.”
Huhtinen, K., Desai, R., Ståhle, M., Salminen, A., Handelsman, D. J., Perheentupa, A., & Poutanen, M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1154 · Cited by 195
Diagnosis and management of endometriosis: summary of NICE guidance
Kuznetsov, L., Dworzynski, K., Davies, M., & Overton, C. (2017) · BMJ · doi:10.1136/bmj.j3935 · Cited by 181
Pretorius, E., Africander, D. J., Vlok, M., Perkins, M. S., Quanson, J., & Storbeck, K.-H. (2016) · PLOS ONE · doi:10.1371/journal.pone.0159867 · Cited by 148 · cited 1×
“11KT can activate androgen-dependent processes with a similar potency to T 12 and in our study was more abundant than T in women with endometriosis.”
Cited by
Endometriosis: “Game changing” new tests may speed up diagnosis in primary care
Wise, J. (2026) · BMJ · doi:10.1136/bmj-2026-100215 · Cited by 1
Metadata
- Authors
- Simitsidellis, I., Ainslie, R. J., Taylor, A. E., Gilligan, L. C., Shaheen, F., Blanke, S., Anderson, C., Hapangama, D., Arlt, W., Horne, A. W., Saunders, P. T. K., & Gibson, D. A.
- Affiliations
- MRC Centre for Reproductive Health (GB)
- Metabolism and Systems Science, School of Medicine and Health, University of Birmingham , Birmingham B15 2TT ,
- University of Birmingham (GB)
- University of Glasgow (GB)
- University of Liverpool (GB)
- MRC London Institute of Medical Sciences (GB)
- Corresponding author
- Gibson, Douglas A
- ORCID
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2026-07-01
- Volume
- 195
- Issue
- 1
- Pages
- 22-34
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- PMC
- PMC13337524
- OpenAlex
- W7167626821
- Cited by
- 1
- References
- 30
- Citations by year
- 2026: 1
- FWCI
- 5.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- European Journal of Endocrinology (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion, cc-by)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by-nc)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion, cc-by-nc)
- Funders
- Wellcome Trust (220656/Z/20/Z, 209492/Z/17/Z)
- Medical Research Council (MRC/IAA/002, MR/N024524/1, MC_UP_1605/15)
- Institute for Regeneration and Repair Innovators award
- MRC
- NIHR
- CSO
- Wellbeing of Women
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- endometriosis, adrenal androgen production, 11-ketotestosterone, 11-oxygenated androgens, diagnostic biomarkers
- MeSH terms
- Adrenal Glands, Adult, Androgens, Endometriosis, Female, Humans, Testosterone, Biomarkers, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Steroid hormone profiling reveals altered adrenal androgen production in endometriosis. https://app.cochat.ai/papers/10.1093/ejendo/lvag109
- The paper
- Simitsidellis, I., Ainslie, R. J., Taylor, A. E., Gilligan, L. C., Shaheen, F., Blanke, S., Anderson, C., Hapangama, D., Arlt, W., Horne, A. W., Saunders, P. T. K., & Gibson, D. A. (2026). Steroid hormone profiling reveals altered adrenal androgen production in endometriosis. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvag109
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.